bluebird bio | 8-K: Current report
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Obenshain Andrew
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Colvin Richard A
bluebird bio | 144: Notice of proposed sale of securities pursuant to Rule 144
bluebird bio | 144: Notice of proposed sale of securities pursuant to Rule 144
bluebird bio | 8-K: Current report
bluebird bio | DEFA14A: Others
bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alyeska Investment Group, L.P.(0.0%),Alyeska Fund GP, LLC(0.0%), etc.
bluebird bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Granahan Investment Management LLC(0.00%)
bluebird bio | 10-Q: Q3 2024 Earnings Report
bluebird bio | 8-K: bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)
bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(1.1 %),GOLDMAN SACHS & CO. LLC(1.1 %)
bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Tita-Reid Najoh
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leschly Nick
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Paulson Richard A.
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Jones-Burton Charlotte
bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Agwunobi John O
No Data